AN ARTICLE ON PERSONS WITH DISABILITIES TANZANIA

PEAH is pleased to post a presentation here focusing on the activities carried out and the challenges faced by the Foundation for Disabilities Hope (FDH) as a Non-Governmental Organization dealing with issues of advocacy for the rights and equality of groups of people with disabilities, youth and children in Tanzania

By Rick Kyando

Programs Manager

Foundation  for Disabilities Hope (FDH), Tanzania

AN ARTICLE ON PERSONS WITH DISABILITIES TANZANIA

  

1.   INTRODUCTION

Foundation for Disabilities Hope (FDH) is a Non-Governmental Organization dealing with issues of Advocacy for the rights and equality of groups of people with disabilities, youth and children. This institution was officially registered in 2019 and obtained National Registration under Act No. 00NGO/R/004. The main office of the foundation is located at the CCM regional office building Dodoma, Tanzania.

2.   ACTIVITIES

We have the mandate to serve people with disabilities all over Tanzania mainland and Zanzibar, until now we have managed to execute the following activities:

a)     Tourism Activity

This is huge activity as we had done on small scale earlier this year but we have planned to do it bigger next year May, 2022 and we welcome all other tourists from all over the world. We initiated a campaign call “TOUR WITH A PERSON WITH DISABILITY AND STAY SAFE BY GETTING VACCINATED”.

We have great support from the Government and other stakeholders and we also invite persons with and without disabilities from all over the world to come join us and enjoy the beautiful view of Tanzania.

b)     Creating Partnership with ADRA Tanzania in Supporting People with Albinism with Hats and sun skin Lotions

This activity is set out to cover large number of people with albinism as we also plan to equip them with soft and hard skills which will help them in earning their income.

c)  Media Tour

On 03rd December, 2021 the disabilities day as a Foundation for Disabilities we used this day to create awareness about the needs and challenges of persons with disabilities through various TV and radio stations.

d)   Agriculture Activity

Since FDH is planning to reach as many marginalized people as possible, the organization launched a farm project which will help people with disabilities to have an alternative way of earning through agriculture, as for now we already have a land, maize and sunflower seeds to start with.

e)     Wheelchair Provision to Beneficiaries

3.     CHALLENGES

With all the achievements depicted above the organization faces some challenges in which some of these are organizational, some departmental and some are personal. The following are challenges in which organization is devoted to solve for smooth operations:

Shortage of fund

The organization faces shortage of fund and because of that all employees are working on volunteering basis. But we appreciate the efforts made from our partner as we keep on assisting those in needs.

 

CONTACT US

Email: foundationfordisabilities@gmail.com WhatsApp number: +255685508510

News Flash 460: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 460

Weekly Snapshot of Public Health Challenges

 

Meeting Registration: Beyond the agenda of the WHO Executive Board: People’s realities, determinants of health, democratic governance… G2H2 meetings, January 2022

OHCHR: Online consultation with civil society “Civil society space: COVID-19: the road to recovery and the essential role of civil society” Please submit the survey before 14 January 2022 at 6 p.m. Geneva time

WHO: reform Involvement of non-State actors in WHO’s governing bodies Report by the Director-General

Recording of the webinar: Care Extractivism

Coronavirus disease (COVID-19) Weekly Update

Do We Need a Pandemic Treaty Now?: Policy Brief by People’s Health Movement

Driven by Omicron, Africa Faces Steep Wave of New COVID Infections; WHO in UN-Geneva Briefing that Excludes Most African Media

Omicron, Africa, and the Need for Much Better Policy from High-Income Countries

The many faces of travel bans

From vaccines to vaccinations: seventh meeting of the Multilateral Leaders Task Force on COVID-19 Vaccines, Therapeutics and Diagnostics

Supporting vaccine rollout in developing countries

Vaccine Famine & its Impact on African Economies

Omicron in South Africa: The Latest News

COVAX: A broken promise to the world

Vaccine Wars: Truth About Pfizer: Dispatches

MSF responds to FDA approval of COVID-19 treatment nirmatrelvir/ritonavir

EMA recommends Nuvaxovid for authorisation in the EU

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

European Commission authorises fifth safe and effective vaccine against COVID-19

Most of the World’s Vaccines Likely Won’t Prevent Infection From Omicron

Moderna Says Existing COVID Vaccine Booster Appears Effective Against Omicron – Higher Dose Performs Even Better

Evidence-based policymaking when evidence is incomplete: The case of HIV programme integration

Liposomal amphotericin B: Solving the access puzzle

‘Biggest killer’ cancer thwarted by home tests, AI

2021 in review: Migration and forced displacement

Book launch + webinar: Are economic inequalities compatible with human rights?

Hearts and minds: How Europeans think and feel about immigration

More Than a Dozen People Dead, 70,000 Displaced in Malaysian Floods

Policy-makers’ perspectives on implementation of cross-sectoral nutrition policies, Western Pacific Region

PepsiCo Foundation to expand U.S. food aid program globally

#ClimatePrescription: “Our handwriting may be bad, but our message is clear” 

Opinion: Opening up energy data is critical to battling climate change

Commission to table green investment rules for gas and nuclear early next year

 

 

 

 

 

 

 

News Flash 459: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 459

Weekly Snapshot of Public Health Challenges

 

 TDR Newsletter December 2021

Meeting registration: Business as usual? The case for transforming global health governance Webinar | January 25 | 15:00 – 16:30 CET

Coronavirus disease (COVID-19) Weekly Update

HOW IS COVID-19 AFFECTING AFRICA?

Omicron variant threatens UN talks to seal global nature deal

Rapidly Spreading Omicron is Now in 77 Countries and WHO Warns Against Assuming its Effects are Mild

Covid-19, the Omicron Variant and the “Butterfly Effect” by Stella Egidi 

Enhancing Readiness for Omicron (B.1.1.529): Technical Brief and Priority Actions for Member States

COVID-19 vaccinations for prison populations and staff: Report on global scan

The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries

Interim recommendations for heterologous COVID-19 vaccine schedules

COVID-19 Vaccine Janssen: EMA recommendation on booster dose

EMA reviewing new data on effectiveness of Lagevrio (molnupiravir) for the treatment of COVID-19

EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19

COVID-19: EMA recommends authorisation of antibody medicine Xevudy

EMA recommends approval for use of Kineret in adults with COVID-19

Researchers Develop Platform to Screen For New Class of Coronavirus Antiviral Compounds

COVID-19 Response: the effectiveness of country-specific measures

DNDi Strategic Plan 2021-2028

TB RESEARCH IN 2020 REACHES ONLY US$915 MILLION – LESS THAN HALF OF INVESTMENT NEEDED TO END TB

Reflections on the Future of the Planet: Antimicrobial Resistance (AMR), Leadership and Humanity

Investing $1 per person could save 7 million lives from heart disease, cancer and diabetes

SDGs at risk in Africa as foreign direct investment declined, UN says

Beyond Expo: Embedding the SDGs in the DNA of Future Technology and Innovation

Alcohol-related harm is a public health issue, not a lifestyle choice

Addiction Is An Emergency: End Wait Times For Services And Expand Access To Life-Saving Medications

Social protection and gender equality outcomes across the lifecycle

UK charities launch appeal to help eight million Afghans at risk of starvation

The road to climate justice

Green mobility and climate justice: how the social score of your neighbourhood affects air pollution

Strengthening Regional Policy Frameworks to Better Respond to Environmental Migration: Recommendations for the UK Government

Commission presents guide for a fair transition towards climate neutrality

WTO Members Launch Historic Statements to ‘Phase Out’ Fossil Fuel Subsidies and Reduce Plastics

Russia vetoes UN resolution linking climate change, security

Parts of Somalia hit by the driest season in 40 years as climate-fueled drought worsens

 

 

 

 

Covid-19, the Omicron Variant and the “Butterfly Effect”

…While western countries are discussing Covid vaccines booster options and are about to throw out about 50 million excess doses by the end of the year (according to Airfinity) the vast majority of countries in the world are far below the minimum coverage level even for vulnerable groups (elderly and people with comorbidity) and health professionals…

 …While scientists are trying to understand the impact of SARS-Cov-2 Omicron variant, the pharmaceutical industry already announced that new versions of the vaccine to fully protect against Omicron will be available by March 2022. Do we really need a new vaccine for this new variant? We don’t know, but we know that the pharma industry is again surfing the wave and ready to make money, and the western governments will eventually pay, even before knowing what data says…

By Stella Egidi

Medical Referent Médecins Sans Frontières Italy

 

 Covid-19, the Omicron Variant and the “Butterfly Effect”

 

The appearance of the Omicron variant has suddenly brought back to global attention the fact that the pandemic is far from being under control and that at every turn of the corner a new unforeseen event might hamper every earlier success.

It has also shown once more the short-sightedness of national strategies that most of countries, primarily western ones, have applied in the face of this pandemic. Since its arrival over a year and a half ago, many first reacted by closing borders and entrenching themselves in their useless national boundaries, despite that evidence shows how ineffective this measure is, bringing instead harmful consequences. In fact, the only result was increasing discrimination and penalizing countries already largely disadvantaged by this epidemic.

The World Health Organization said the highly mutated Omicron variant of Covid-19 could change the course of the pandemic[i]. The main concern is related to its high transmissibility, currently leading to a new Covid-19 wave in Southern Africa, that could allow this variant to quickly replace Delta worldwide (the variant is expected to be dominant in Europe by February-March[ii]).

What to expect exactly is “still difficult to know” according to WHO Director General Tedros Adhanom Ghebreyesus. “Certain features of Omicron, including its global spread and large number of mutations, suggest it could have a major impact on the course of the pandemic”. The reality, however, is that very little is known so far about the potential impact of the new variant, especially its severity. Paradoxically, if a lower severity of clinical manifestations than Delta is confirmed, considering the high transmission rate and the fast spread amongst susceptible people, the Omicron variant could even become an advantage. Scientists around the world are currently struggling to get data and understand how contagious and lethal this new variant will be on a large scale.

What we know for sure is the detrimental impact produced by travel bans immediately put in place by many countries. An increasing number of countries are closing borders, prohibiting the arrival of international travelers from Southern African countries where the new variant is being detected. Countries affected by the restrictions are already experiencing heavy economic, commercial and political consequences of this decision, which was not based on any scientific evidence. Ironically, instead of being rewarded for their prompt and efficient surveillance system that allowed other countries to prepare themselves and the scientific community to explore and study the new variant early on in order to find solutions, these countries are being “punished” as the so-called “plague spreaders”.

The WHO had already clearly advised many months ago against travel bans and advocated for countries to continue applying an evidence-informed and risk-based approach when implementing travel measures.

Even in cases when such measures could be effective in mitigating the spread to some degree, they are largely taken when it’s too late. With the Omicron variant it has been demonstrated that the new strain was already circulating in Europe at the time it was detected and announced by South African authorities (whose public health surveillance system was simply the most efficient at detecting it!). So far, according to available data, the Omicron variant has been confirmed in 57 countries[iii].

As WHO has stated, “Blanket travel bans will not prevent the international spread, and they place a heavy burden on lives and livelihoods. In addition, they can adversely impact global health efforts during a pandemic by disincentivizing countries to report and share epidemiological and sequencing data. Alternative measures, like screening of passengers prior to travelling and/or upon arrival, including via the use of SARS-CoV-2 testing or the application of quarantine to international travelers defined following a thorough risk assessment process informed by the local epidemiology in departure and destination countries, and commensurate with the risk, time-limited and applied with respect to travelers’ dignity, human rights and fundamental freedoms might be applied to mitigate the potential impact of variant spreading and to fight the epidemic in a more rational way”[iv].

Very little is known about the impact of the new variant on vaccines. A first small study[v] showed a decrease in antibody protection against the new variant, but we know how to identify antibody level with the broader immune protection, given the complexity of this last, can be misleading. While scientists are trying to understand the impact, the pharmaceutical industry already announced that new versions of the vaccine[vi] to fully protect against Omicron will be available by March 2022. Do we really need a new vaccine for this new variant? We don’t know, but we know that the pharma industry is again surfing the wave and ready to make money, and the western governments will eventually pay, even before knowing what data says.

The Omicron variant has also again brought to light the high inequality that has affected middle and low income countries throughout the epidemic more than ever before. Excellent documentation[vii] has spelled out how heavy and long-lasting the impact of the pandemic has been on the poorest countries, and that they not only have been affected by the virus far more than available data shows (we know how weak are surveillance systems in poorest countries) but are paying the heaviest burden in terms of economic impact and ability to recover.

Those who lost income due to the pandemic have been almost twice as likely to spend their assets or savings, leaving them less able to cope with continued or recurrent income losses.

In turn this will likely lead to progressive increase in impoverishing poor; lead to job losses, hamper productivity, stop income growth, increase soil exploitation, and result in deepening economic dependance of the poorest countries on external aid and push more population towards global migration.

How to reverse this vicious circle? To simplify a complex topic, we could say: by giving Covid-19 vaccines to the poorest. This is surely an oversimplification, we can agree; but it is now indisputable that global availability and equal access to vaccines for all countries in the world is a paramount step in the race for global safety and wellbeing.

While western countries are discussing booster options and are about to throw out about 50 million excess doses by the end of the year (according to Airfinity[viii]), the vast majority of countries in the world are far below the minimum coverage level even for vulnerable groups (elderly and people with comorbidity) and health professionals. Full vaccination coverage for Africa is about 7% according to WHO[ix], an average value which hides even worse realities, like Democratic Republic of Congo, where the coverage is around 0,1% of the population. In fact, high-income countries received 16 times more vaccines per capita than poorer nations, according to the Financial Times analysis[x].

As always, the richest countries are (or they pretend to be) so blind that they do not understand that if just for the sake of solidarity and equity, they need to take on the responsibility of tackling this issue. Variants will keep on emerging, and they will likely do so faster where the vaccination coverage is low or patchy and the virus will keep on circulating at a high rate. They will also continue circulating far beyond our ability to detect and stop them in time. After Omicron, there will likely be a new variant; after Sars-Cov-2, there will likely be a new pandemic one day or another, starting in some little corner of the world. The “butterfly effect[xi]” has never been so real.

 

[i] https://www.cnbc.com/2021/12/08/who-says-omicron-covid-variant-could-change-the-course-of-the-pandemic.html

[ii] https://www.ecdc.europa.eu/sites/default/files/documents/threat-assessment-covid-19-emergence-sars-cov-2-variant-omicron-december-2021.pdf

[iii] https://www.theguardian.com/world/2021/dec/09/omicron-spreads-to-57-countries-but-too-early-to-tell-if-variant-more-infectious-who-says

[iv]https://www.who.int/news-room/articles-detail/who-advice-for-international-traffic-in-relation-to-the-sars-cov-2-omicron-variant

[v] https://www.npr.org/sections/goatsandsoda/2021/12/08/1062352212/studies-suggest-sharp-drop-in-vaccine-protection-v-omicron-yet-cause-for-optimis?t=1639067508470

[vi] https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-omicron-variant

[vii] https://www.weforum.org/platforms/covid-action-platform/articles/covid19-rising-poverty-widening-inequality

[viii] https://www.wamc.org/2021-11-08/low-income-nations-need-covid-vaccines-rich-countries-have-millions-of-unused-doses

[ix]https://app.powerbi.com/view?r=eyJrIjoiY2ViYzIyZjItYzhkMi00ZWVkLTgyM2ItZTk1ZTJmODRjMTkxIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9

[x] https://www.ft.com/content/0e240929-033a-457f-a735-ec7cf93b2f3c

[xi] https://en.wikipedia.org/wiki/Butterfly_effect

News Flash 458: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 458

Weekly Snapshot of Public Health Challenges

 

Comic Series: The Power of the 99% to Stop Corporate Capture

Challenging violence against women in public life

WHO: Public health round-up

Coronavirus disease (COVID-19) Weekly Update

Towards a universal understanding of post COVID-19 condition

Why South Africa keeps detecting COVID-19 variants like omicron

As 57 Countries Report Omicron Cases, Pfizer Says its Boosters Offer Protection – But WHO Cautions More Research is Needed

Audio Interview: Waning Immunity against SARS-CoV-2

Webinar registration: Covid-19 Pandemic and Health Policy Responses: a critical analysis. Saturday 11 December 2021, 10:00-13:30 UTC+2

‘Dangerously Unprepared’: New Report Faults Countries’ Pandemic Readiness… Again

One year after the first shot, pharma must urgently “share the tech” of COVID-19 vaccines

WIPO SCP 33: Statement of Knowledge Ecology International on patents and health

EMA and ECDC recommendations on heterologous vaccination courses against COVID-19

Updated interim recommendations for the use of the Janssen Ad26.COV2.S (‎COVID-19)‎ vaccine

US Announces ‘Global VAX’ to Push COVID-19 Vaccination Effort Worldwide

Optimizing the supply of vaccines for COVID-19

Pfizer Could Have Done More to Help Low-Income Countries Handle Vaccines, CEO Says

India’s SII promises 40 mln more AstraZeneca doses to COVAX this year

Addressing production gaps for vaccines in African countries

African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production

Aspen’s COVID-19 vaccine licensing deal a ‘game changer’ for Africa

Exclusive: Up to 1 million COVID vaccines expired in Nigeria last month

EMA recommends approval for use of RoActemra in adults with severe COVID-19

The Medicines Patent Pool and the University of Washington sign a licence agreement for an investigational long-acting injectable drug combination candidate for HIV

More malaria cases and deaths in 2020 linked to COVID-19 disruptions

WHO: World Malaria Report 2021

WHO welcomes historic decision by Gavi to fund the first malaria vaccine

Will climate change-fueled drought spur more yellow fever outbreaks?

As Antimicrobial Resistance Advances, We Need Action to Stop a Predictable Catastrophe

Nigerian Exchange to Boost Food Output With $100 Million Bond

Policy-makers’ perspectives on implementation of cross-sectoral nutrition policies, Western Pacific Region

All coral reefs in western Indian Ocean ‘at high risk of collapse in next 50 years’

EU lawmakers call for tougher rules on live animal transport

Glyphosate approval: stakeholders squabble over who has the science right

 

 

 

 

 

 

 

 

News Flash 457: Weekly Snapshot of Public Health Challenges

News Flash Links, as part of the research project PEAH (Policies for Equitable Access to Health), aim to focus on the latest challenges by trade and governments rules to equitable access to health in resource-limited settings

News Flash 457

Weekly Snapshot of Public Health Challenges

 

BOOK Political Journeys in Health: Essays by and for Amit Sengupta Information regarding the book can be found here: https://mayday.leftword.com/catalog/product/view/id/2219

Tripartite and UNEP support OHHLEP’s definition of “One Health”: Joint Tripartite (FAO, OIE, WHO) and UNEP Statement

Webinar registration: European Cross-border Initiatives: Toward Fair Medicine Deals? Dec 9, 2021 02:00 PM in Brussels

Do We Need a Pandemic Treaty Now?: Policy Brief by People’s Health Movement

1 December 2021: World Health Assembly agrees to launch process to develop historic global accord on pandemic prevention, preparedness and response

Landmark decision by the World Health Assembly to start negotiations for a pandemic treaty

Special session of World Health Assembly 29 November 2021 – 1 December 2021

Join Event: GLOBAL HEALTH CENTRE OPTIONS, OUTCOMES AND OPPORTUNITIES: REFLECTING ON THE WHA SPECIAL SESSION 03 December 2021, 15:00 – 16:15 World Health Assembly Open Briefing Online Discussion, 3pm CET

Join Event: GLOBAL HEALTH CENTRE FINANCING WHO WELL: LOW-HANGING FRUIT OR MISSION IMPOSSIBLE? 07 December 2021, 16:00 – 17:00 Online Event, 4pm CET

Coronavirus disease (COVID-19) Weekly Update

WHO: Tracking SARS-CoV-2 variants

WHO: Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern

The Omicron Variant of COVID-19: A Q&A With Virologist Andrew Pekosz

SARS-Cov-2 Omicron Variant: Holding Our Leaders Accountable by Raymond Saner

COVAX, partners call for changes in donated doses in 2022

China’s Xi Jinping pledges another 1 billion COVID-19 vaccine doses for African nations

Eyeing COVID Through PEAH Independent Lens: Which Takeaways? by Daniele Dionisio

African Countries Will Continue to Face Tough Choices on COVID-19 Vaccines: We’ve Developed a Toolkit That Can Help

States must prioritize health and equality over profits and vaccine hoarding, UN experts say Omicron and other new variants underline urgency to act 

Time to ‘think about mandatory vaccination’: EU chief

Response to Covid-19 pandemic from a community engagement perspective: Sweden vs India in waves one and two

In the wake of postponement of WTO’s Ministerial, MSF underscores the urgency of adopting the TRIPS Waiver for people’s unhindered access to COVID-19 medical tools

Why don’t we just open the windows?

The theme of this year’s World AIDS Day is “END INEQUALITIES. END AIDS. END PANDEMICS”.

World AIDS Day: Pandemics Thrive on Inequity

Millions of AIDS-related Deaths in Years to Come if Global Inequalities Remain Unaddressed, UNAIDS Warns Ahead of World AIDS Day

Working Close to Home to Prevent HIV

COVID-19 response allowing epidemics like tuberculosis to mount a comeback

Preserving antibiotics in times of COVID-19 – how stewardship teams involving hospital pharmacists can contribute

Launch of ESNO Focus Group: AMR, Vaccination & Infection Prevention

#MEPvsAMR: preventing antimicrobial resistance requires concerted efforts at the national and European level

Policy briefing I The interplay between antimicrobial resistance and COVID-19

Position Paper I A Joint response to the European Commission’s Pharmaceutical Strategy for Europe

Register: Call to Action Launch: A right to a healthy environment that works Online Event Wed, 8 December 2021 14:00 – 14:45 CET

Submission to the OHCHR Annual Report on Human Rights and Climate Change

Decarbonizing the U.S. Health Sector — A Call to Action

Fighting Loss of the Greater Mekong’s Prized Rosewood Forests